Reported Awareness and Adoption of 2021 Estimated Glomerular Filtration Rate Equations Among US Clinical Laboratories, March 2022

Jonathan R Genzen; Rhona J Souers; Lauren N Pearson; David M Manthei; Allison B Chambliss; Zahra Shajani-Yi; W Greg Miller

doi:10.1001/jama.2022.15404

Reported Awareness and Adoption of 2021 Estimated Glomerular Filtration Rate Equations Among US Clinical Laboratories, March 2022

JAMA. 2022 Nov 22;328(20):2060-2062. doi: 10.1001/jama.2022.15404.

Authors

Jonathan R Genzen¹, Rhona J Souers², Lauren N Pearson¹, David M Manthei³, Allison B Chambliss⁴, Zahra Shajani-Yi⁵, W Greg Miller⁶

Affiliations

¹ Department of Pathology, University of Utah Health, Salt Lake City.
² Department of Biostatistics, College of American Pathologists, Northfield, Illinois.
³ Department of Pathology, University of Michigan, Ann Arbor.
⁴ Department of Pathology, University of Southern California, Los Angeles.
⁵ Laboratory Corporation of America Holdings, San Diego, California.
⁶ Department of Pathology, Virginia Commonwealth University, Richmond.

No abstract available

Plain language summary

This study includes clinical laboratories that participated in the first general chemistry proficiency testing survey in 2022 to assess awareness and adoption of new equations from the Chronic Kidney Disease Epidemiology Collaboration for estimated glomerular filtration rate (eGFR) that eliminated race-adjustment factors, including one based on creatinine and one based on creatinine and cystatin C.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Clinical Laboratory Services* / standards
Creatinine
Glomerular Filtration Rate*
Guideline Adherence*
Health Knowledge, Attitudes, Practice
Laboratories, Clinical* / standards
United States

Substances

Creatinine